<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02662517</url>
  </required_header>
  <id_info>
    <org_study_id>UHCologne</org_study_id>
    <nct_id>NCT02662517</nct_id>
  </id_info>
  <brief_title>Growth Hormones and Cells in Human Milk Depending on Gestational Age</brief_title>
  <acronym>BMProfile</acronym>
  <official_title>Growth Hormones and Cells in Human Milk Depending on Gestational Age and Lactation Phase</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human breast milk contains growth factors including neurotrophins and cells with
      neuroprotective potential. Concerning growth factors milk of preterms differs significantly
      from term milk. The aim of this study is to give a profile of human milk concerning
      non-nutritive factors depending on gestational age and lactation phase.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neurotrophins (epidermal growth factor (EGF), vascular endothelial growth factor (VEGF),
      nerve growth factor (NGF), brain derived neurotrophic factor (BDNF)) as well as amount of
      cells, especially positive for sex-determining transformer protein (TRA)-1-81 and
      stage-specific embryonic antigen (SSEA)-4, are planned to be quantified in human breast milk
      of extremely preterm newborns as well as term newborns at different stages of lactation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 1, 2016</start_date>
  <completion_date type="Actual">January 1, 2017</completion_date>
  <primary_completion_date type="Actual">September 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>neurotrophins composition</measure>
    <time_frame>day 7</time_frame>
    <description>Concentration of Neurotrophins EGF, VEGF, NGF, BDNF in the human milk</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amount of cells positive for surface markers TRA-1-81 and SSEA-4</measure>
    <time_frame>day 7</time_frame>
    <description>surface markers characteristic for pluripotent stem cells</description>
  </secondary_outcome>
  <enrollment type="Actual">43</enrollment>
  <condition>Lactation</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      human breast milk, umbilical chord blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Breastfeeding mothers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the newborn infant is being fed with own mothers milk

        Exclusion Criteria:

          -  low amount of breast milk
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Titus Keller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology, University Hospital of Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neonatology at the University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Keller T, Wengenroth L, Smorra D, Probst K, Kurian L, Kribs A, Brachvogel B. Novel DRAQ5™/SYTOX® Blue Based Flow Cytometric Strategy to Identify and Characterize Stem Cells in Human Breast Milk. Cytometry B Clin Cytom. 2019 Nov;96(6):480-489. doi: 10.1002/cyto.b.21748. Epub 2018 Nov 26.</citation>
    <PMID>30479054</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 11, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2016</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Cologne</investigator_affiliation>
    <investigator_full_name>Titus Keller, MD</investigator_full_name>
    <investigator_title>Neonatologist</investigator_title>
  </responsible_party>
  <keyword>Neurotrophins</keyword>
  <keyword>Stem Cells</keyword>
  <keyword>Prematurity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

